Kiniksa Pharmaceuticals International (KNSA) Change in Acquisitions & Divestments (2018 - 2026)

Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $145.7 million for Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 230.83% year-over-year to $145.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $301.1 million (up 35.59% YoY) and the FY2025 annual result came in at $199.5 million, down 16.86% from the prior year.
• Change in Acquisitions & Divestments was $145.7 million for Q1 2026 at Kiniksa Pharmaceuticals International, up from $40.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $145.7 million in Q1 2026 and bottomed at $7.5 million in Q1 2022.
• A 5-year average of $52.3 million and a median of $44.0 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments sank 94.61% — and 2024, when it surged 312.56%.
• Kiniksa Pharmaceuticals International's Change in Acquisitions & Divestments stood at $20.1 million in 2022, then surged by 128.75% to $46.0 million in 2023, then jumped by 90.26% to $87.5 million in 2024, then plunged by 53.38% to $40.8 million in 2025, then jumped by 257.17% to $145.7 million in 2026.
• Business Quant data shows KNSA's Change in Acquisitions & Divestments at $145.7 million in Q1 2026, $40.8 million in Q4 2025, and $84.1 million in Q3 2025.